Working… Menu

A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01889186
Recruitment Status : Active, not recruiting
First Posted : June 28, 2013
Last Update Posted : June 7, 2019
Genentech, Inc.
Information provided by (Responsible Party):